CCEGC(600939)
Search documents
重庆建工(600939.SH):联合体中标17.14亿元工程项目
Ge Long Hui A P P· 2025-12-09 07:54
格隆汇12月9日丨重庆建工(600939.SH)公布,公司之全资子公司重庆交通建设(集团)有限责任公司(简 称"交建集团")和重庆建工市政交通工程有限责任公司(简称"市政交通公司")组建的联合体,参与八横线 白市驿隧道至黄桷坪长江大桥段工程施工二标段项目投标。近日,联合体已收到中标通知书,确认其中 标该项目,中标价17.14亿元。 ...
重庆建工:联合体中标17.14亿元工程项目
Xin Lang Cai Jing· 2025-12-09 07:54
重庆建工公告称,其全资子公司交建集团与市政交通公司组建的联合体,中标八横线白市驿隧道至黄桷 坪长江大桥段工程施工二标段项目,中标价17.14亿元。项目位于重庆大渡口区、九龙坡区,工期2160 日历天。交建集团为牵头人,负责主办协调工作,各方承担施工任务待划分。截至公告日,项目未签正 式合同,预计对当期营收、利润影响有限。 ...
重庆建工(600939) - 开万梁公司2024年度审计报告
2025-12-08 11:17
扫描全能王 创建 l i 限公司 重庆开 E II 5 级 资审计 9年度财经 告 报 ff 廣华表审(2025) A116 号 重庆康华会计师事务所(特殊普通合伙) 二〇二五年四月 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公允反映 了贵公司 2024年12月 31日的财务状况以及 2024年度的经营成果和现金流量。 1 重庆 康 华 会 计 师 事 务 所 CHONGOING KANGHUA CPAs 二、形成审计意见的基础 康华表审(2025) A116 号 重庆开万梁高速公路有限公司全体股东; 一、审计意见 我们审计了重庆开万梁高速公路有限公司(以下简称贵公司)财务报表,包括2024 年 12月 31日的资产负债表和资产减值准备情况表,2024年度的利润表、现金流量表、所 有者权益变动表和国有资本权益变动情况表以及相关财务报表附注。 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计师 对财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。按照中国注册会计 师职业道德守则,我们独立于贵公司,并履行了职业道德方面的其他责任。我们相信,我 们获取的审计 ...
重庆建工(600939) - 重庆建工关于公司董事、总经理离任暨聘任总经理、提名董事候选人的公告
2025-12-08 11:15
| 证券代码:600939 | 证券简称:重庆建工 | | 公告编号:临 | 2025-119 | | --- | --- | --- | --- | --- | | 转债代码:110064 | 转债简称:建工转债 | | | | | 债券代码:254104 | 债券简称:24 01 | 渝建 | | | 重庆建工集团股份有限公司 关于公司董事、总经理离任暨聘任总经理、提名董事 候选人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、董事/高级管理人员离任情况 (一)提前离任的基本情况 | | | | | 原定任期到 | | | | 是否继续在上 | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 离任时间 | | 期日 | | | 离任原因 | 市公司及其控 股子公司任职 | 履行完毕的 公开承诺 | | 周进 | 董事、董事 会提名委员 会和战略委 | 年 2025 12 月 5 ...
重庆建工(600939) - 重庆建工关于全资子公司为关联参股公司提供担保的公告
2025-12-08 11:15
| 证券代码:600939 | 证券简称:重庆建工 | | 公告编号:临 2025-120 | | --- | --- | --- | --- | | 转债代码:110064 | 转债简称:建工转债 | | | | 债券代码:254104 | 债券简称:24 | 渝建 01 | | 重庆建工集团股份有限公司 关于全资子公司为关联参股公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | | | 被担保人名称 | 重庆开万梁高速公路有限公司 | | --- | --- | --- | --- | | | | 被担保人关联关系 | □控股股东、实际控制人及其控制的 主体 | | | | | □上市公司董事、高级管理人员及其 | | | | | 控制或者任职的主体 | | | | | ☑其他重庆开万梁高速公路有限公 | | | | | 司(以下简称"开万梁高速公司") | | | | | 系持有重庆建工集团股份有限公司 | | | | | (以下简称"公司")5%以上股份的 | | | | | 大股东 ...
重庆建工(600939) - 重庆建工第五届董事会第五十次会议决议公告
2025-12-08 11:15
重庆建工集团股份有限公司 第五届董事会第五十次会议决议公告 | 转债代码:110064 | 转债简称:建工转债 | | | | | | --- | --- | --- | --- | --- | --- | | 证券代码:600939 债券代码:254104 | 证券简称:重庆建工 债券简称:24 | 渝建 | 01 | 公告编号:临 | 2025-118 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 重庆建工集团股份有限公司(以下简称"公司")于 2025 年 12 月 5 日发出召开第五届董事会第五十次会议的通知。公司第五届董事会 第五十次会议于 2025 年 12 月 8 日以通讯方式召开。会议应参与表决 的董事 7 人,实际参与表决的董事 7 人。 本次会议的召集、召开、审议程序符合《中华人民共和国公司法》 等有关法律法规及《重庆建工集团股份有限公司章程》的有关规定。 会议的召集、召开及所作决议合法有效。 二、董事会会议审议情况 (一)逐项审议通过了《关于提名公司董事会成员的议案》《 ...
重庆建工:全资子公司拟为关联参股公司提供7000万元担保
Xin Lang Cai Jing· 2025-12-08 11:04
重庆建工公告称,为保障重庆开州至梁平高速公路项目建设与运营,其全资子公司市政一公司持有开万 梁高速公司7%股份,拟为其按持股比例提供7000万元连带责任保证担保,占公司最近一期经审计净资 产的比例为0.90%。截至2025年11月30日,公司及控股子公司对外担保总额141.68亿元,占最近一期经 审计净资产的181.59%。本次担保事项尚需提交公司股东会审议。 ...
重庆国企改革板块12月8日跌0.03%,渝三峡A领跌,主力资金净流出366.85万元





Sou Hu Cai Jing· 2025-12-08 09:25
Core Viewpoint - The Chongqing state-owned enterprise reform sector experienced a slight decline of 0.03% on December 8, with the leading stock, Yuzhong Sanxia A, falling by 2.44% [1][2]. Market Performance - The Shanghai Composite Index closed at 3924.08, up by 0.54% - The Shenzhen Component Index closed at 13329.99, up by 1.39% [1]. Stock Performance in Chongqing State-Owned Enterprises - Key stocks in the Chongqing state-owned enterprise reform sector showed mixed performance, with notable declines in several stocks: - Qianli Technology (601777) rose by 1.17% to 10.42 - ST Huicheng (002168) increased by 1.08% to 3.73 - Southwest Securities (600369) rose by 0.67% to 4.52 - Yuzhong Sanxia A (000565) fell by 2.44% to 7.61, leading the decline [1][2]. Trading Volume and Value - The trading volume and value for key stocks included: - Qianli Technology: 275,200 shares traded, with a transaction value of 289 million - ST Huicheng: 44,200 shares traded, with a transaction value of 16.44 million - Yuzhong Sanxia A: 148,700 shares traded, with a transaction value of 114 million [1][2]. Capital Flow Analysis - On the same day, the Chongqing state-owned enterprise reform sector saw a net outflow of 3.6685 million from institutional investors and 4.7398 million from speculative funds, while retail investors had a net inflow of 8.4084 million [2][3]. Individual Stock Capital Flow - Notable capital flows for individual stocks included: - Qianli Technology had a net inflow of 38.1921 million from institutional investors - ST Huicheng experienced a net outflow of 2.1304 million from institutional investors - Yuzhong Sanxia A had a significant net outflow of 13.3430 million from institutional investors [3].
格隆汇公告精选︱博汇纸业:拟投资17亿元规划年产32万吨化学浆项目;福蓉科技:产品本身不具有AI功能
Ge Long Hui· 2025-12-04 21:23
Key Points - Company Grinda plans to invest 80 million yuan to subscribe for 1.91% of Muxi's initial public offering shares [1] - Fuyong Technology clarifies that its products do not possess AI capabilities [1] - Bohui Paper Industry intends to invest 1.7 billion yuan to establish a project with an annual production capacity of 320,000 tons of chemical pulp [1] - Jinggong Technology has won the bid for the Wuhan Qingshan high-performance carbon fiber production base project [1] - Yonghe Intelligent Control plans to transfer 100% equity and debt of its wholly-owned subsidiary Chengdu Shanshui [2] - Zhigang Home plans to repurchase shares with an investment of 80 million to 110 million yuan [2] - Meikailong's shareholder Hangzhou Haoyue intends to reduce its holdings by no more than 131 million shares [2] - International Medical plans to raise no more than 1.008 billion yuan through a private placement [2] - Guizhou Bailin's actual controller Jiang Wei has received a notice of investigation from the Securities Regulatory Commission [2]
12月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-03 10:19
Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]